SB

Sangeetha Baroor

Active Director Director DIN 10773210
DIN 10773210 First appointment Sep 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sangeetha Baroor

Data last updated:

Sangeetha Baroor is a Director at Maxiviris Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10773210
Primary Designation Director
Industry Pharma
First Appointment 09 Sep 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Sep 20242024Active

Board colleagues of Sangeetha Baroor

NameDINCompanyDesignation
Baroor Ashok Kumar10773211Maxiviris Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Maxiviris Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sangeetha Baroor

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sangeetha Baroor

Sangeetha Baroor currently holds 1 directorship: Maxiviris Pharmaceuticals Private Limited (Director, since 09 Sep 2024).

Sangeetha Baroor was first appointed on 09 Sep 2024 as Director at Maxiviris Pharmaceuticals Private Limited.

The current boards of Sangeetha Baroor's companies include Baroor Ashok Kumar (Maxiviris Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available